Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Canagliflozin

An SGLT2 inhibitor (gliflozin) for type 2 diabetes: it stops the kidneys from reabsorbing glucose, which is then passed in the urine. Approved in 2013, it was the first of its class in the United States. This family brings together the active ingredient, metabolites, labelled standards and other impurities.

Did you know?Gliflozins descend from phlorizin, a bitter-tasting substance isolated in 1835 from the root bark of the apple tree.

CanagliflozinGo to the active ingredient →
CanagliflozinActive ingredientCanagliflozinCat. No. P-C017-001CAS 842133-18-0

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.